Anatara Lifesciences Ltd (ANR.AX)

AUD 0.01

(0.0%)

Operating Expenses Summary of Anatara Lifesciences Ltd

  • Anatara Lifesciences Ltd's latest annual operating expenses in 2024 was 710.21 Thousand AUD , down -78.22% from previous year.
  • Anatara Lifesciences Ltd's latest quarterly operating expenses in 2024 FY was 2.1 Million AUD , down -35.56% from previous quarter.
  • Anatara Lifesciences Ltd reported a annual operating expenses of 3.26 Million AUD in annual operating expenses 2023, up 8.76% from previous year.
  • Anatara Lifesciences Ltd reported a annual operating expenses of 2.99 Million AUD in annual operating expenses 2022, down -3.51% from previous year.
  • Anatara Lifesciences Ltd reported a quarterly operating expenses of 92.37 Thousand AUD for 2024 Q4, down 0.0% from previous quarter.
  • Anatara Lifesciences Ltd reported a quarterly operating expenses of 953.85 Thousand AUD for 2024 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Anatara Lifesciences Ltd (2024 - 2013)

Historical Annual Operating Expenses of Anatara Lifesciences Ltd (2024 - 2013)

Year Operating Expenses Operating Expenses Growth
2024 710.21 Thousand AUD -78.22%
2023 3.26 Million AUD 8.76%
2022 2.99 Million AUD -3.51%
2021 3.1 Million AUD -25.86%
2020 4.18 Million AUD 44.58%
2019 2.89 Million AUD -3.72%
2018 3 Million AUD -16.23%
2017 3.59 Million AUD 35.81%
2016 2.64 Million AUD 32.44%
2015 1.99 Million AUD 181.67%
2014 709.17 Thousand AUD 572.76%
2013 105.41 Thousand AUD 0.0%

Peer Operating Expenses Comparison of Anatara Lifesciences Ltd

Name Operating Expenses Operating Expenses Difference
AdAlta Limited 6.76 Million AUD 89.509%
Acrux Limited 8.55 Million AUD 91.693%
Race Oncology Limited 14.77 Million AUD 95.192%
Biome Australia Limited 7.91 Million AUD 91.023%
Botanix Pharmaceuticals Limited 601.82 Thousand AUD -18.012%
BTC Health Limited -1.03 Million AUD 168.361%
Chimeric Therapeutics Limited 19.76 Million AUD 96.407%
CSL Limited 7.56 Billion AUD 99.991%
Clarity Pharmaceuticals Ltd 56.3 Million AUD 98.739%
Clinuvel Pharmaceuticals Limited 31.29 Million AUD 97.731%
EZZ Life Science Holdings Limited 39.57 Million AUD 98.205%
Hexima Limited 1 Million AUD 29.594%
Immutep Limited 42.87 Million AUD 98.344%
Memphasys Limited 3.67 Million AUD 80.692%
Neuren Pharmaceuticals Limited 32.69 Million AUD 97.828%
Noxopharm Limited 7 Million AUD 89.854%
Prescient Therapeutics Limited 10.89 Million AUD 93.484%
Radiopharm Theranostics Limited 299.22 Thousand AUD -137.35%
Starpharma Holdings Limited 22.81 Million AUD 96.887%
Tissue Repair Ltd 6.66 Million AUD 89.347%
Biotron Limited 5.11 Million AUD 86.103%
Alterity Therapeutics Limited 23.4 Million AUD 96.966%
Bio-Gene Technology Limited 2.76 Million AUD 74.277%
Zelira Therapeutics Limited 5.94 Million AUD 88.061%
Patrys Limited 4.93 Million AUD 85.604%
Orthocell Limited 15.36 Million AUD 95.379%
Imugene Limited 135.09 Million AUD 99.474%
PYC Therapeutics Limited 60.91 Million AUD 98.834%
Proteomics International Laboratories Limited 892.14 Thousand AUD 20.392%
Cynata Therapeutics Limited 11.12 Million AUD 93.615%
Arovella Therapeutics Limited 10.78 Million AUD 93.415%
Nanollose Limited 12.5 Thousand AUD -5581.281%
Invex Therapeutics Ltd 3.34 Million AUD 78.773%
NeuroScientific Biopharmaceuticals Limited 1.96 Million AUD 63.861%
Amplia Therapeutics Limited 8.43 Million AUD 91.581%
Island Pharmaceuticals Limited 4.12 Million AUD 82.784%
Nyrada Inc. 4.55 Million AUD 84.409%
Telix Pharmaceuticals Limited 269.26 Million AUD 99.736%
Dimerix Limited 25.64 Million AUD 97.23%
PharmAust Limited 6.65 Million AUD 89.331%
AnteoTech Limited 12.18 Million AUD 94.172%
Paradigm Biopharmaceuticals Limited 65.1 Million AUD 98.909%
Recce Pharmaceuticals Ltd 21.68 Million AUD 96.725%
Avecho Biotechnology Limited 4.54 Million AUD 84.375%
Actinogen Medical Limited 22.77 Million AUD 96.881%
Immuron Limited 9.13 Million AUD 92.228%
Argenica Therapeutics Limited 8.26 Million AUD 91.411%